Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01728220
Recruitment Status : Completed
First Posted : November 19, 2012
Last Update Posted : February 18, 2015
Information provided by (Responsible Party):
Bellerophon ( Bellerophon Pulse Technologies )

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : June 2014
  Study Completion Date : July 2014
  Certification/Extension First Submitted : January 30, 2015